NPI: 1194009274 · NEW BRUNSWICK, NJ 08901 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/06/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/06/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,608 | $1.51M |
| 2019 | 11,279 | $1.51M |
| 2020 | 14,323 | $984K |
| 2021 | 16,816 | $839K |
| 2022 | 16,648 | $778K |
| 2023 | 11,685 | $209K |
| 2024 | 8,096 | $545K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 38,354 | 2,824 | $4.91M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,707 | 1,142 | $617K |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,375 | 1,110 | $514K |
| J1756 | Injection, iron sucrose, 1 mg | 6,842 | 1,328 | $119K |
| A4657 | Syringe, with or without needle, each | 11,619 | 1,942 | $75K |
| 85041 | 453 | 413 | $31K | |
| 85048 | 449 | 411 | $31K | |
| 83970 | 281 | 253 | $30K | |
| 82728 | 201 | 193 | $18K | |
| 83550 | 195 | 190 | $17K | |
| 83540 | 194 | 189 | $17K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,084 | 424 | $0.00 |
| OP250 | 359 | 20 | $0.00 | |
| 90662 | 22 | 13 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 55 | 42 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 160 | 109 | $0.00 |
| 90674 | 86 | 48 | $0.00 | |
| 0001A | 19 | 13 | $0.00 |